What if transplant patients could one day live free from lifelong anti-rejection drugs?
In this episode of Mayo Clinic's Tomorrow’s Cure, host Lindsey Seavert speaks with Timucin Taner, M.D., Ph.D. from Mayo Clinic and Angus Thomson, Ph.D. from University of Pittsburgh Medical Center about one of the biggest goals in transplant medicine: teaching the immune system to accept a donated organ instead of attacking it. From the liver’s unique ability to promote immune tolerance to promising cell therapies and donor-derived treatments, the conversation explores how researchers are working to retrain the immune system, reduce side effects, and improve long-term outcomes for transplant recipients. Along the way, they discuss the future of kidney, heart, and lung transplantation, the promise of xenotransplantation, and how breakthroughs in transplant science may also help advance treatment for autoimmune disease.
How to listen and stay connected:
Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode.
Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc
Connect with Mayo Clinic:
Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/
Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/
Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic
Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
Fler avsnitt av Tomorrow's Cure
Visa alla avsnitt av Tomorrow's CureTomorrow's Cure med Mayo Clinic finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
